Samil Pharmaceutical Co.,Ltd (KRX:000520)

KRX:000520 Revenue

In the year 2025, Samil Pharmaceutical Co.,Ltd had annual revenue of 210.25B KRW, down -4.30%. Samil Pharmaceutical Co.,Ltd had revenue of 53.00B in the quarter ending December 31, 2025, a decrease of -8.28%.

• Revenue: 210.25B
• Revenue Growth: -4.30%
• P/S Ratio: 0.97
• Revenue / Employee: 360.64M
• Employees: 583
• Market Cap: 203.59B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	210.25B	-9.45B	-4.30%
Dec 31, 2024	219.70B	23.35B	11.89%
Dec 31, 2023	196.35B	16.67B	9.28%
Dec 31, 2022	179.68B	45.43B	33.84%
Dec 31, 2021	134.25B	11.25B	9.14%